Status: current, Defined. Date: 31-Dec 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4278251000168111 | Aimovig (erenumab 140 mg / 1 mL) injection, 1 mL pen device (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4278261000168113 | Aimovig 140 mg/mL injection, 1 mL pen device | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Aimovig 140 mg/mL injection, 1 mL pen device | Is a | Aimovig | true | Inferred relationship | Some | ||
| Aimovig 140 mg/mL injection, 1 mL pen device | Is a | erenumab 140 mg/mL injection, pen device | true | Inferred relationship | Some | ||
| Aimovig 140 mg/mL injection, 1 mL pen device | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Aimovig 140 mg/mL injection, 1 mL pen device | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Aimovig 140 mg/mL injection, 1 mL pen device | has Australian BoSS | erenumab | true | Inferred relationship | Some | 612302118 | |
| Aimovig 140 mg/mL injection, 1 mL pen device | has intended active ingredient | erenumab | true | Inferred relationship | Some | 612302118 | |
| Aimovig 140 mg/mL injection, 1 mL pen device | has unit of use | pen device | true | Inferred relationship | Some | 2011112251 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Aimovig 140 mg/mL injection, 1 mL pen device | has TPUU | True | Aimovig 140 mg/mL injection, 1 mL pen device | Inferred relationship | Some | 783890096 |
| Aimovig 140 mg/mL injection, 1 mL pen device | has TPUU | True | Aimovig 140 mg/mL injection, 1 mL pen device | Inferred relationship | Some | 365958610 |
Reference Sets
Black Triangle Scheme reference set
Trade product unit of use reference set
FHIR